PharmExec.com Featured TBRC's Biologics Global Market Report 2018
On July 10th, 2018, PharmExec, released an article on the global Organ-On-Chip market, sourced from TBRC`s report on the global biologics market. According to the article, biologics are very large complex molecules manufactured in living systems such as microorganisms, animal cells or plant cells. Monoclonal antibodies (mAbs) are the largest segment of the biologics market, followed by therapeutic proteins and vaccines. All three segments are growing at over 9% year on year. North America is the leading region for both biologic and other pharma sales.